INTEGRATION OF RETROVIRAL DNA--ACCESSING HOST TARGET DNA
$420,397R01FY2000CANIH
Institute For Cancer Research, Philadelphia PA
Investigators
Linked publications & trials
Paper 27835934Paper 26958915Paper 26104370Paper 25844274Paper 25642713Paper 25147916Paper 24884573Paper 24637393Paper 24209742Paper 23322775Paper 23221555Paper 22145019Paper 21622554Paper 21454648Paper 20861255Paper 20686665Paper 19880521Paper 19563676Paper 19010419Paper 18687138Paper 18094192Paper 17202206Paper 15855529Paper 15795247Paper 15761474Paper 15681408Paper 15669021Paper 15479807Paper 15308627Paper 15280466Paper 15140982Paper 15078971Paper 15018700Paper 14645598Paper 12679521Paper 11991971Paper 11821409Paper 11821408Paper 11805085Paper 11533219Paper 11441016Paper 11238839Paper 11169922Paper 11158303Paper 10969077
Abstract
DESCRIPTION: The goals of this study are to better understand the mechanism of retroviral DNA integration into the host genome and to evaluate its potential for the practical application in gene therapy. The specific aims are 1) to determine the role of ASV integrase (IN) in the nuclear entry and DNA targeting of the ASV preintegration complex focussing on the nuclear localization signal (NLS) and its potential interacting cellular proteins; and 2) to determine if DNA integration can be targeted to specific sites in host cell chromatin using ASV IN fusion protein.
View original record on NIH RePORTER →